aluates Reports

$ 0.0

Automative

Global Biologics Monoclonal Antibodies Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-39T13737

Global Biologics Monoclonal Antibodies Drug Market Research Report 2023

BUY CHAPTERS

Global Biologics Monoclonal Antibodies Drug Market Research Report 2025

Code: QYRE-Auto-39T13737

Report

May 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi

Johnson & Johnson

Pfizer Inc

Eli Lilly

Novartis

Merck

Biogen

SOBI

Innovent Biologics

Biologics Monoclonal Antibodies Drug Market Size

The global market for Biologics Monoclonal Antibodies Drug was valued at US$ 264010 million in the year 2024 and is projected to reach a revised size of US$ 577400 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Biologics Monoclonal Antibodies Drug Market

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.

The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.

This report aims to provide a comprehensive presentation of the global market for Biologics Monoclonal Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Monoclonal Antibodies Drug.

The Biologics Monoclonal Antibodies Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Monoclonal Antibodies Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics Monoclonal Antibodies Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biologics Monoclonal Antibodies Drug Market Report

Report Metric	Details
Report Name	Biologics Monoclonal Antibodies Drug Market
Accounted market size in year	US$ 264010 million
Forecasted market size in 2031	US$ 577400 million
CAGR	12.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Infliximab Rituximab Trastuzumab Adalimumab Other
Segment by Application	Cancer Autoimmune Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Merck, Biogen, Sobi, Innovent Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Monoclonal Antibodies Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biologics Monoclonal Antibodies Drug Market growing?

Ans: The Biologics Monoclonal Antibodies Drug Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Biologics Monoclonal Antibodies Drug Market size in 2031?

Ans: The Biologics Monoclonal Antibodies Drug Market size in 2031 will be US$ 577400 million.

Who are the main players in the Biologics Monoclonal Antibodies Drug Market report?

Ans: The main players in the Biologics Monoclonal Antibodies Drug Market are Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Merck, Biogen, Sobi, Innovent Biologics

What are the Application segmentation covered in the Biologics Monoclonal Antibodies Drug Market report?

Ans: The Applications covered in the Biologics Monoclonal Antibodies Drug Market report are Cancer, Autoimmune Disease, Other

What are the Type segmentation covered in the Biologics Monoclonal Antibodies Drug Market report?

Ans: The Types covered in the Biologics Monoclonal Antibodies Drug Market report are Infliximab, Rituximab, Trastuzumab, Adalimumab, Other

Recommended Reports

Monoclonal Antibodies

Immunology Therapies

Biologic & Biosimilar Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Infliximab

1.2.3 Rituximab

1.2.4 Trastuzumab

1.2.5 Adalimumab

1.2.6 Other

1.3 Market by Application

1.3.1 Global Biologics Monoclonal Antibodies Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Autoimmune Disease

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biologics Monoclonal Antibodies Drug Market Perspective (2020-2031)

2.2 Global Biologics Monoclonal Antibodies Drug Growth Trends by Region

2.2.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biologics Monoclonal Antibodies Drug Historic Market Size by Region (2020-2025)

2.2.3 Biologics Monoclonal Antibodies Drug Forecasted Market Size by Region (2026-2031)

2.3 Biologics Monoclonal Antibodies Drug Market Dynamics

2.3.1 Biologics Monoclonal Antibodies Drug Industry Trends

2.3.2 Biologics Monoclonal Antibodies Drug Market Drivers

2.3.3 Biologics Monoclonal Antibodies Drug Market Challenges

2.3.4 Biologics Monoclonal Antibodies Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biologics Monoclonal Antibodies Drug Players by Revenue

3.1.1 Global Top Biologics Monoclonal Antibodies Drug Players by Revenue (2020-2025)

3.1.2 Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Players (2020-2025)

3.2 Global Biologics Monoclonal Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biologics Monoclonal Antibodies Drug Revenue

3.4 Global Biologics Monoclonal Antibodies Drug Market Concentration Ratio

3.4.1 Global Biologics Monoclonal Antibodies Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biologics Monoclonal Antibodies Drug Revenue in 2024

3.5 Global Key Players of Biologics Monoclonal Antibodies Drug Head office and Area Served

3.6 Global Key Players of Biologics Monoclonal Antibodies Drug, Product and Application

3.7 Global Key Players of Biologics Monoclonal Antibodies Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biologics Monoclonal Antibodies Drug Breakdown Data by Type

4.1 Global Biologics Monoclonal Antibodies Drug Historic Market Size by Type (2020-2025)

4.2 Global Biologics Monoclonal Antibodies Drug Forecasted Market Size by Type (2026-2031)

5 Biologics Monoclonal Antibodies Drug Breakdown Data by Application

5.1 Global Biologics Monoclonal Antibodies Drug Historic Market Size by Application (2020-2025)

5.2 Global Biologics Monoclonal Antibodies Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biologics Monoclonal Antibodies Drug Market Size (2020-2031)

6.2 North America Biologics Monoclonal Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025)

6.4 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biologics Monoclonal Antibodies Drug Market Size (2020-2031)

7.2 Europe Biologics Monoclonal Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025)

7.4 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size (2020-2031)

8.2 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biologics Monoclonal Antibodies Drug Market Size (2020-2031)

9.2 Latin America Biologics Monoclonal Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025)

9.4 Latin America Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size (2020-2031)

10.2 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biologics Monoclonal Antibodies Drug Introduction

11.1.4 Roche Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Biologics Monoclonal Antibodies Drug Introduction

11.2.4 Amgen Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biologics Monoclonal Antibodies Drug Introduction

11.3.4 AbbVie Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Biologics Monoclonal Antibodies Drug Introduction

11.4.4 Sanofi Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.4.5 Sanofi Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Introduction

11.5.4 Johnson & Johnson Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biologics Monoclonal Antibodies Drug Introduction

11.6.4 Pfizer Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Introduction

11.7.4 Eli Lilly Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.7.5 Eli Lilly Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Biologics Monoclonal Antibodies Drug Introduction

11.8.4 Novartis Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Biologics Monoclonal Antibodies Drug Introduction

11.9.4 Merck Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.9.5 Merck Recent Development

11.10 Biogen

11.10.1 Biogen Company Details

11.10.2 Biogen Business Overview

11.10.3 Biogen Biologics Monoclonal Antibodies Drug Introduction

11.10.4 Biogen Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.10.5 Biogen Recent Development

11.11 Sobi

11.11.1 Sobi Company Details

11.11.2 Sobi Business Overview

11.11.3 Sobi Biologics Monoclonal Antibodies Drug Introduction

11.11.4 Sobi Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.11.5 Sobi Recent Development

11.12 Innovent Biologics

11.12.1 Innovent Biologics Company Details

11.12.2 Innovent Biologics Business Overview

11.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Introduction

11.12.4 Innovent Biologics Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025)

11.12.5 Innovent Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi

Johnson & Johnson

Pfizer Inc

Eli Lilly

Novartis

Merck

Biogen

SOBI

Innovent Biologics

List of Tables

Table 1. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Infliximab

Table 3. Key Players of Rituximab

Table 4. Key Players of Trastuzumab

Table 5. Key Players of Adalimumab

Table 6. Key Players of Other

Table 7. Global Biologics Monoclonal Antibodies Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Biologics Monoclonal Antibodies Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2020-2025)

Table 11. Global Biologics Monoclonal Antibodies Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2026-2031)

Table 13. Biologics Monoclonal Antibodies Drug Market Trends

Table 14. Biologics Monoclonal Antibodies Drug Market Drivers

Table 15. Biologics Monoclonal Antibodies Drug Market Challenges

Table 16. Biologics Monoclonal Antibodies Drug Market Restraints

Table 17. Global Biologics Monoclonal Antibodies Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Biologics Monoclonal Antibodies Drug Market Share by Players (2020-2025)

Table 19. Global Top Biologics Monoclonal Antibodies Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Monoclonal Antibodies Drug as of 2024)

Table 20. Ranking of Global Top Biologics Monoclonal Antibodies Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Biologics Monoclonal Antibodies Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Biologics Monoclonal Antibodies Drug, Headquarters and Area Served

Table 23. Global Key Players of Biologics Monoclonal Antibodies Drug, Product and Application

Table 24. Global Key Players of Biologics Monoclonal Antibodies Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Biologics Monoclonal Antibodies Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Biologics Monoclonal Antibodies Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Roche Company Details

Table 50. Roche Business Overview

Table 51. Roche Biologics Monoclonal Antibodies Drug Product

Table 52. Roche Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 53. Roche Recent Development

Table 54. Amgen Company Details

Table 55. Amgen Business Overview

Table 56. Amgen Biologics Monoclonal Antibodies Drug Product

Table 57. Amgen Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 58. Amgen Recent Development

Table 59. AbbVie Company Details

Table 60. AbbVie Business Overview

Table 61. AbbVie Biologics Monoclonal Antibodies Drug Product

Table 62. AbbVie Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 63. AbbVie Recent Development

Table 64. Sanofi Company Details

Table 65. Sanofi Business Overview

Table 66. Sanofi Biologics Monoclonal Antibodies Drug Product

Table 67. Sanofi Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 68. Sanofi Recent Development

Table 69. Johnson & Johnson Company Details

Table 70. Johnson & Johnson Business Overview

Table 71. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product

Table 72. Johnson & Johnson Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 73. Johnson & Johnson Recent Development

Table 74. Pfizer Company Details

Table 75. Pfizer Business Overview

Table 76. Pfizer Biologics Monoclonal Antibodies Drug Product

Table 77. Pfizer Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 78. Pfizer Recent Development

Table 79. Eli Lilly Company Details

Table 80. Eli Lilly Business Overview

Table 81. Eli Lilly Biologics Monoclonal Antibodies Drug Product

Table 82. Eli Lilly Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 83. Eli Lilly Recent Development

Table 84. Novartis Company Details

Table 85. Novartis Business Overview

Table 86. Novartis Biologics Monoclonal Antibodies Drug Product

Table 87. Novartis Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 88. Novartis Recent Development

Table 89. Merck Company Details

Table 90. Merck Business Overview

Table 91. Merck Biologics Monoclonal Antibodies Drug Product

Table 92. Merck Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 93. Merck Recent Development

Table 94. Biogen Company Details

Table 95. Biogen Business Overview

Table 96. Biogen Biologics Monoclonal Antibodies Drug Product

Table 97. Biogen Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 98. Biogen Recent Development

Table 99. Sobi Company Details

Table 100. Sobi Business Overview

Table 101. Sobi Biologics Monoclonal Antibodies Drug Product

Table 102. Sobi Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 103. Sobi Recent Development

Table 104. Innovent Biologics Company Details

Table 105. Innovent Biologics Business Overview

Table 106. Innovent Biologics Biologics Monoclonal Antibodies Drug Product

Table 107. Innovent Biologics Revenue in Biologics Monoclonal Antibodies Drug Business (2020-2025) & (US$ Million)

Table 108. Innovent Biologics Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Biologics Monoclonal Antibodies Drug Picture

Figure 2. Global Biologics Monoclonal Antibodies Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biologics Monoclonal Antibodies Drug Market Share by Type: 2024 VS 2031

Figure 4. Infliximab Features

Figure 5. Rituximab Features

Figure 6. Trastuzumab Features

Figure 7. Adalimumab Features

Figure 8. Other Features

Figure 9. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Biologics Monoclonal Antibodies Drug Market Share by Application: 2024 VS 2031

Figure 11. Cancer Case Studies

Figure 12. Autoimmune Disease Case Studies

Figure 13. Other Case Studies

Figure 14. Biologics Monoclonal Antibodies Drug Report Years Considered

Figure 15. Global Biologics Monoclonal Antibodies Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Biologics Monoclonal Antibodies Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Biologics Monoclonal Antibodies Drug Market Share by Region: 2024 VS 2031

Figure 18. Global Biologics Monoclonal Antibodies Drug Market Share by Players in 2024

Figure 19. Global Top Biologics Monoclonal Antibodies Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Monoclonal Antibodies Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Biologics Monoclonal Antibodies Drug Revenue in 2024

Figure 21. North America Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Biologics Monoclonal Antibodies Drug Market Share by Country (2020-2031)

Figure 23. United States Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Biologics Monoclonal Antibodies Drug Market Share by Country (2020-2031)

Figure 27. Germany Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Share by Region (2020-2031)

Figure 35. China Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Biologics Monoclonal Antibodies Drug Market Share by Country (2020-2031)

Figure 43. Mexico Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country (2020-2031)

Figure 47. Turkey Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Biologics Monoclonal Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Roche Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 51. Amgen Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 52. AbbVie Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 55. Pfizer Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 56. Eli Lilly Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 57. Novartis Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 59. Biogen Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 60. Sobi Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 61. Innovent Biologics Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

Global Antibody Drugs Market Insights Forecast to 2030

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Arthritis Monoclonal Antibodies Market Research Report 2024

Global Antibody Production Services Market Research Report 2024

Global Monoclonal Antibodies Product Market Research Report 2024

Global Rabies Virus Monoclonal Antibody Market Research Report 2024

Global Antibody Market Insights Forecast to 2030

Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti HA Antibody Market Research Report 2024

Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoantibody Kit Market Insights Forecast to 2030

Global Combination Antibody Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions